STRS Ohio’s Kezar Life Sciences KZR Stock Holding History

STRS Ohio’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-150	Closed	-$25K	–	2198
2021 Q4	$25K	Hold	150	–	–	﹤0.01%	2093
2021 Q3	$12K	Hold	150	–	–	﹤0.01%	2197
2021 Q2	$8K	Hold	150	–	–	﹤0.01%	2202
2021 Q1	$8K	Hold	150	–	–	﹤0.01%	2137
2020 Q4	$7K	Hold	150	–	–	﹤0.01%	2121
2020 Q3	$7K	Hold	150	–	–	﹤0.01%	2147
2020 Q2	$7K	Hold	150	–	–	﹤0.01%	2114
2020 Q1	$6K	Hold	150	–	–	﹤0.01%	1968
2019 Q4	$6K	Hold	150	–	–	﹤0.01%	2023
2019 Q3	$4K	Hold	150	–	–	﹤0.01%	2050
2019 Q2	$11K	Hold	150	–	–	﹤0.01%	2072
2019 Q1	$26K	Hold	150	–	–	﹤0.01%	1949
2018 Q4	$35K	Hold	150	–	–	﹤0.01%	1925
2018 Q3	$32K	Buy	+150	New	+$26.2K	﹤0.01%	1996

Other funds holding KZR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

STRS Ohio's KZR Position: Q1 2022 in Review

STRS Ohio sold out of Kezar Life Sciences (KZR) in Q1 2022, closing a stake of 150 shares — an estimated $25K sold.

STRS Ohio first reported a position in KZR in Q3 2018 and held it in 14 quarters. The position peaked at $35K in Q4 2018. 123 funds tracked by Wall St. Rank hold KZR as of Q1 2022.

STRS Ohio reported no remaining Kezar Life Sciences position as of Q1 2022 after selling out during the quarter.
STRS Ohio sold 150 Kezar Life Sciences shares in Q1 2022, an estimated $25K.
STRS Ohio first reported a position in Kezar Life Sciences in Q3 2018 and held it in 14 quarters.
STRS Ohio's Kezar Life Sciences position peaked at $35K in Q4 2018.
123 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2022.

Based on STRS Ohio's 13F filing for Q1 2022, filed 21 Apr 2022.